AZGP1 antibody (AA 61-210)
-
- Target See all AZGP1 Antibodies
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
-
Binding Specificity
- AA 61-210
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This AZGP1 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Cross-Reactivity
- Human
- Purification
- >95%, Protein G purified
- Immunogen
- Recombinant Human Zinc-alpha-2-glycoprotein protein (61-210AA)
- Isotype
- IgG
- Top Product
- Discover our top product AZGP1 Primary Antibody
-
-
- Application Notes
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
- Alternative Name
- AZGP1 (AZGP1 Products)
- Synonyms
- Zag antibody, ZA2G antibody, ZAG antibody, ZA2GA antibody, Zna2gp antibody, alpha-2-glycoprotein 1, zinc antibody, alpha-2-glycoprotein 1, zinc-binding antibody, Azgp1 antibody, AZGP1 antibody
- Background
-
Background: Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids.
Aliases: Alpha 2 glycoprotein 1 zinc antibody, Alpha 2 glycoprotein 1 zinc binding antibody, Alpha 2 glycoprotein zinc antibody, Azgp1 antibody, ZA2G antibody, ZA2G_HUMAN antibody, ZAG antibody, Zinc alpha 2 glycoprotein precursor antibody, Zinc-alpha-2-glycoprotein antibody, Zn alpha 2 glycoprotein antibody, Zn alpha 2 GP antibody, Zn alpha2 glycoprotein antibody, Zn-alpha-2-glycoprotein antibody, Zn-alpha-2-GP antibody, ZNGP1 antibody
- UniProt
- P25311
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-